Measurement of plasma 5-hydroxyindoleacetic acid as a possible clinical surrogate marker for the action of antivascular agents.

Measurement of plasma 5-hydroxyindoleacetic acid as a possible clinical surrogate marker for the action of antivascular agents.

BACKGROUND: Serotonin (5HT), a naturally occurring vasoactive substance, is released from platelets into plasma under various pathological conditions. Recently, anticancer drugs that act by selectively disrupting tumour blood flow have been found to increase plasma 5HT concentrations in mice. Two su...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Kestell, P, Zhao, L, Jameson, M, Stratford, MR, Folkes, L, Baguley, B
Formato:	Journal article
Idioma:	English
Publicado em:	2001

Registros relacionados

Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection.
por: Stratford, MR, et al.
Publicado em: (2011)

Rat Tumor Response to the Vascular-Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Plasma 5-Hydroxyindoleacetic Acid Levels, and Tumor Necrosis
por: Lesley D. McPhail, et al.
Publicado em: (2006-03-01)

A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation.
por: Stratford, MR, et al.
Publicado em: (2012)

Serum 5-Hydroxyindoleacetic Acid and Ratio of 5-Hydroxyindoleacetic Acid to Serotonin as Metabolomics Indicators for Acute Oxidative Stress and Inflammation in Vancomycin-Associated Acute Kidney Injury
por: Hyun-Seung Lee, et al.
Publicado em: (2021-06-01)

Quantitative determination of the anticancer prodrug combretastatin A1 phosphate (OXi4503, CA1P), the active CA1 and its glucuronide metabolites in human urine and of CA1 in plasma by HPLC with mass spectrometric detection.
por: Stratford, MR, et al.
Publicado em: (2012)

Use of Arsenic Trioxide as an Antivascular and Thermosensitizing Agent in Solid Tumors
por: Robert J. Griffin, et al.
Publicado em: (2000-01-01)

Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection
por: Stratford, M, et al.
Publicado em: (2011)

5-Hydroxyindoleacetic acid as a biomarker for revealing perforation in acute appendicitis
por: Arash Mohammadi Tofigh, et al.
Publicado em: (2024-10-01)

Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid
por: Korrapati V. Sathyasaikumar, et al.
Publicado em: (2022-08-01)

Impact of plasma 5-hydroxyindoleacetic acid, a serotonin metabolite, on clinical outcome in septic shock, and its effect on vascular permeability
por: Takeshi Tanaka, et al.
Publicado em: (2021-07-01)

Autoimmune Pancreatitis Associated with High Levels of Chromogranin A, Serotonin and 5-Hydroxyindoleacetic Acid
por: Elisabetta Nobili, et al.
Publicado em: (2008-01-01)

A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation
por: Stratford, M, et al.
Publicado em: (2012)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
por: Ilias Zampros, et al.
Publicado em: (2012-01-01)

Zinc-Substituted Pheophorbide A Is a Safe and Efficient Antivascular Photodynamic Agent
por: Milena J. Szafraniec, et al.
Publicado em: (2022-02-01)

Promising novel treatment against keloids: Antivascular endothelial growth factor agents
por: Bahareh Abtahi-Naeini, et al.
Publicado em: (2019-01-01)

Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity.
por: Hoskin, P, et al.
Publicado em: (2000)

Surgical Correction of Carcinoid Heart Disease Improves Liver Function and 5-Hydroxyindoleacetic Acid Levels
por: Husnain Abbas Shah, et al.
Publicado em: (2022-04-01)

Influence of plasma glutathione levels on radiation mucositis.
por: Wardman, P, et al.
Publicado em: (2001)

Bypass of Tumor Drug Resistance by Antivascular Therapy
por: Dina Preise, et al.
Publicado em: (2003-11-01)

5-Hydroxyindoleacetic acid, a new ligand for GPR35, plays an important role in inflammatory disease
por: Yang Zhisheng, et al.
Publicado em: (2022-12-01)

The correlation between urinary 5-hydroxyindoleacetic acid and sperm quality in infertile men and rotating shift workers
por: Pariente José A, et al.
Publicado em: (2010-11-01)

Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levels
por: Christopher Adams, et al.
Publicado em: (2023-01-01)

Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy
por: Kumar Anshuman, et al.
Publicado em: (2019-01-01)

Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer
por: Xiaocong Ma, et al.
Publicado em: (2023-04-01)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Ajay Indur Dudani, et al.
Publicado em: (2019-01-01)

Multi-omic Profiling Reveals that Intra-abdominal-Hypertension-Induced Intestinal Damage Can Be Prevented by Microbiome and Metabolic Modulations with 5-Hydroxyindoleacetic Acid as a Diagnostic Marker
por: Fang Li, et al.
Publicado em: (2022-06-01)

Increase of Urinary 5-Hydroxyindoleacetic Acid Excretion but Not Serum Chromogranin a Following Over-The-Counter 5-Hydroxytryptophan Intake
por: Tisha Joy, et al.
Publicado em: (2008-01-01)

5-Fluoroindole-3-acetic acid: a prodrug activated by a peroxidase with potential for use in targeted cancer therapy.
por: Folkes, L, et al.
Publicado em: (2002)

Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer
por: Chueh-Yi Huang, et al.
Publicado em: (2016-06-01)

Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma.
por: Merryl R Lobo, et al.
Publicado em: (2015-01-01)

Assessment of Serotonin Metabolite 5-hydroxyindoleacetic Acid Levels in Urine Sample for Diagnosis and Treatment Efficacy in Children with Dysfunctional Voiding and Their Interaction with Biofeedback Therapy
por: Bahadır Topuz, et al.
Publicado em: (2018-12-01)

Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity.
por: Bruno B Andrade, et al.
Publicado em: (2010-04-01)

Acute renal failure after intravitreal antivascular endothelial growth factor therapy
por: Yu-Fang Huang, et al.
Publicado em: (2017-06-01)

Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
por: Tranos P, et al.
Publicado em: (2013-06-01)

Intravitreal antivascular endothelial growth factors for retinopathy of prematurity in Ibadan: Method of administration
por: Yewande Olubunmi Babalola, et al.
Publicado em: (2020-01-01)

Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor
por: Yukio Sassa, et al.
Publicado em: (2010-04-01)

Surrogate markers in HIV disease.
por: Peto, T
Publicado em: (1996)

Surrogates Markers of Insulin Resistance
por: Ekhlas Khalid Hameed, et al.
Publicado em: (2022-05-01)

Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings
por: Ashwini Shete, et al.
Publicado em: (2020-07-01)

Oxidative metabolism of combretastatin A-1 produces quinone intermediates with the potential to bind to nucleophiles and to enhance oxidative stress via free radicals.
por: Folkes, L, et al.
Publicado em: (2007)